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BACKGROUND  
Introduction 
The starting point of my interest in this field was an impression that in many children with acute 
signs of joint swelling or refusal to move an arm or a leg, the parents or the children would refer to 
a trauma at the onset of the symptoms. In many cases there would also be a history of recent 
infection.  
As toddlers often stumble and fall, a history of trauma may be a coincidence. On the other 
hand, a fall could be the result of a pathologic joint or bone process or lead to disruption of the 
endothelium or other mechanisms allowing bacteria to invade the bone.  
Children frequently have infections and a recent infection could also be a coincidence; 
nevertheless infections could cause a bacteraemia followed by osteomyelitis or septic arthritis or 
activate the immune system so that joint inflammation occurs.  
If doctors are consulted they have a challenge whether to “wait and see” or adopt adequate 
tests and manage further follow-up and treatment. During my first years of training in paediatrics I 
experienced that the management of these children varied.  
I found the search for the location and possible cause of the signs and symptoms as 
challenging and interesting. Especially, I enjoyed the teamwork that could involve physiotherapists, 
orthopaedic surgeons, oncologists, ophthalmologists, cardiologists, rheumatologists, infectious 
disease specialists, microbiologists, radiologists, gastroenterologists and many more. 
Arthritis is an inflammation of the synovia of the joints1. Osteomyelitis is an infection 
characterised by inflammatory destruction and new apposition of bone 2. The presence of inflamed 
synovia and/or joint effusion adjacent to the site of bone infection may reflect septic arthritis or 
non-septic arthritis.  
Most studies present patients with chronic arthritis, or selected groups of patients with 
arthritis or osteomyelitis based on retrospective methodology at hospitals or questionnaires to 
primary care physicians. Retrospective case series from hospitals tend to be biased toward the more 
ill patients. Studies based on questionnaires may be limited by variability in examination of 
patients and limited exclusion of other diagnosis.  
Epidemiological studies want to describe the natural history and outcome in different 
disease entities. They may predict early prognostic factors and may help understanding how 
subgroups of disease present. Differences between regions and time could generate hypotheses 
regarding environmental and genetic factors. Prospective studies on incidence, disease course, 
diagnostic tests and sequelae may improve health care management of children with acute onset 
musculoskeletal features. 
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Childhood arthritis 
Arthritis in childhood comprises joint infections, post- or parainfectious arthritis, transient arthritis, 
chronic arthritis or arthritis associated with a wide range of other conditions 3. The arthritic disease 
may be migratory, non-migratory, involve one or many joints and may affect other organ systems 
such as heart, skin and eyes 3-5. There are classification criteria and several studies on chronic 
arthritis and acute rheumatic fever (ARF), but little data and no classification criteria for the other 
types of childhood arthritis 4, 6.  
The incidence of arthritis in children has been reported in a Finnish study from 1986 at 109 
per 100 000 children, in a German study from 2001 at 83 per 100 000 and in a small Finnish study 
from 2003 at 64 per 100 000 3, 7, 8. However, in the German study the subgroups of arthritis were 
not explained in detail and the recruitment was based on questionnaires distributed to primary care 
physicians. Kunnamo et al found that 71% had transient arthritis, 17% had chronic arthritis, 6% 
had septic arthritis and 5% had post infectious arthritis (enteropathic arthritis) 3.  
 
Chronic arthritis 
Chronic arthritis is the most common chronic rheumatic disease in children.  It comprises a 
heterogenous group of inflammatory disorders that affects joints, bone, muscle and connective 
tissue and is an important cause of short-term and long-term disability in children 5. The first 
classification criteria were proposed by Ansell and Bywaters in 1959 9. In the 1970s two sets of 
criteria were proposed: the criteria for juvenile rheumatoid arthritis (JRA) developed by the 
American College of Rheumatology (ACR)10 and the criteria for juvenile chronic arthritis (JCA) 
published by the European League Against Rheumatism (EULAR)11.  Different classification 
criteria for juvenile arthritis made a comparison of studies difficult and the Pediatric Standing 
Committee of the International League of Association for Rheumatology (ILAR) was challenged to 
develop a new set of criteria in 1993. In 2004 the second revision of criteria for juvenile idiopathic 
arthritis (JIA) was published 6. JIA is arthritis of unknown etiology that has persisted for more than 
six weeks with onset before the age of 16 years 6.  The new criteria classified JIA into the following 
subgroups: systemic arthritis, oligoarthritis, RF-negative polyarthritis, RF-positive polyarthritis, 
psoriatic arthritis, enthesitis related arthritis and undifferentiated arthritis (Table 1).12 
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Table 1. Comparison of Classifications of Childhood Arthritis* 
 
Criteria ACR EULAR ILAR 
Terminology Juvenile rheumatoid arthritis 
(JRA) 
Juvenile chronic arthritis (JCA) Juvenile idiopathic arthritis 
(JIA) 
Basis of classification Clinical Clinical and serologic (RF) Clinical and serologic (RF) 
 Onset and course Onset only Onset and course 
Age at onset of arthritis  16 yr  16 yr  16 yr 
Duration of arthritis  6 wk  3 mo  6 wk 
Subgroups Systemic Systemic Systemic 
 Polyarticular Polyarticular JCA Polyarticular RF-negative 
  Juvenile rheumatoid arthritis Polyarticular RF-positive 
 Pauciarticular Pauciarticular Oligoarticular 
     Persistent 
     Extended 
  Juvenile psoriatic arthritis (JPsA) Psoriatic arthritis 
  Juvenile ankylosing spondylitis 
(JAS) 
Enthesitis-related arthritis 
  Arthritis of IBD Other arthritis 
    
Excluded subgroups JAS   
 JPsA   
 Arthritis of IBD   
Exclusion of other 
diseases 
Yes Yes Yes 
 
*based on Textbook of Pediatric Rheumatology. ACR, American College of Rheumatology; EULAR, European League Against 
Rheumatism; ILAR, International League of Associations for Rheumatology; IBD, inflammatory bowel disease; JAS juvenile 
ankylosing spondylitis; JPsA, juvenile psoriatic arthritis; RF, rheumatoid factor. 
 
Chronic childhood arthritis has been described in all races and geographical areas; however, its 
incidence and prevalence vary considerably 13. A review found that the prevalence was higher in 
population-based studies and in North American studies. Clinical-based studies were more 
homogenous in results. Diagnostic criteria or duration of the studies had no impact, although the 
study sample may have been too small to detect such differences.  
The incidence of juvenile chronic arthritis in Finland, Norway and Sweden has been 
reported at 11-23 cases per 100 000 per year, which is higher than rates reported from other 
European countries 3, 14-18.  Oligoarthritis represents the most common onset type accounting for 
50% to 75% of all cases 13. More girls than boys are affected, although the sex distribution varies 
with disease subtype with female to male ratio 2-3 to 1 in the oligo-and polyarticular onset groups, 
an even distribution of systemic onset arthritis and a male predominance in enthesitis related 
arthritis 16, 19, 20. Two major peaks in onset are observed at 1-2 years and 9-15 years of age 14, 16, 21. 
The knees are most commonly involved 22, 23. 
Antinuclear antibodies (ANA) are detected in up to 50% of patients with oligoarthritis and 
they represent a risk factor for iridocyclitis. Rheumatoid-factor-positive polyarthritis is similar to 
adult RF-positive rheumatoid arthritis and is mainly seen in adolescent girls. Many of these patients 
also have antibodies against cyclic citrullinated peptide (CCP) 12. The cause and pathogenesis of 
JIA seem to include both genetic and environmental components 24, 25. The first genome-wide scan 
supports that several genes, including at least one in the HLA region affects the susceptibility to 
JIA 26. Many associations between subsets of JIA and HLA or non-HLA molecules have been 
described 25, 27, 28. Most patients with enthesitis-related arthritis are reported to be HLA-B27 
positive 29. Newer studies have found that 40-60% of patients have remission at follow-up 5, 14. 
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Indicators of poor outcome are severity and number of joints, wrist or hip involvement, presence of 
RF, persistent active disease and early radiographic changes 30. The use of steroids can also cause 
severe growth retardation and osteoporosis 31, 32. 
Only one previous study has focused on identifying clinical and laboratory features that 
may predict the evolution into chronic arthritis among patients with early onset arthritis. Kunnamo 
et al found  that a low CRP value, the absence of fever and an elevated IgG were independent 
factors for chronic arthritis in patients whose disease duration exceeded two weeks 23. 
 
Post- and parainfectious arthritis 
Post- and parainfectious arthritis comprises a heterogenic group including viral arthritis, acute 
rheumatic fever (ARF), post-streptococcal arthritis (PSRA) and arthritis following genitourinary 
tract or gastrointestinal tract infections (reactive arthritis) of a specific organism. 
ARF is a connective tissue disease characterised by an inflammatory process that affects 
several organs of the body. An epidemiological association between S. pyogenes and ARF has been 
established 33. The Jones Criteria for guidance in the diagnosis of ARF  were initially proposed by 
T. Duckett Jones, in 1944 34. Committees of the American Heart Association have modified, 
revised and edited these criteria and the last update came in 1992. The criteria were established to 
guide physicians in the diagnosis and to minimise its over diagnosis. The major manifestations are 
carditis, polyarthritis, chorea, erythema marginatum and subcutaneous nodules. The minor 
manifestations are arthralgia, fever, elevated acute phase reactants, and prolonged PR interval on 
electrocardiogram. “If supported by evidence of preceding of group A streptococcal infection, the 
presence of two major manifestations or of one major and two minor manifestations indicates a 
high probability of acute rheumatic fever”4. 
Data of high quality on the incidence of ARF are scarce. In developed countries there was a 
significant decrease after the 1950s. By 1994 it was estimated to be below 1 per 100 000 35. A few 
studies from developing countries have estimated an annual incidence of 1.0 per 100 000 in Costa 
Rica, 72 per 100 000 in Sudan and 150 per 100 000 in China 35, 36. The annual incidence also differ 
between population groups within countries such as Samoans and Chinese on Hawaii and 
Aboriginals (> 200 per 100 000) and non-Aboriginals in Australia 37.  Determinants of the ARF 
epidemic are socioeconomic and environmental factors and health-system related factors 38, 39. In 
the early 1990s it was said that 12 million people suffered from ARF of whom at lest 3 million had 
congestive heart failure. Although initial attacks of ARF can lead to rheumatic heart disease it is 
usually the results of recurrent attacks of ARF. The prevalence of rheumatic heart disease peaks at 
age 25-34 40. Penicillin treatment and long-term penicillin prophylaxis is recommended in children 
with ARF 4. 
In 1982 Goldsmith and Long described a post-streptococcal syndrome in children that was 
characterised by arthritis but was clinically different from ARF 41. In 1997 Ayoub and Ahmed 
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proposed criteria for post-streptococcal reactive arthritis (PSRA): A) Characteristics of arthritis: 1. 
Acute-onset arthritis, symmetric or asymmetric, usually non migratory, can affect any joint. 2. 
Persistent or recurrent. 3. Poorly responsive to salicylates or non steroidal anti-inflammatory drugs. 
B) Evidence of antecedent group A streptococcal infection. C) Does not fulfil the modified Jones 
criteria for the diagnosis of ARF 42. Most authors have suggested that PSRA is a distinct clinical 
identity that must be distinguished from ARF, while others consider it to be a part of the spectrum 
of ARF 41, 43-45. In PSRA, cardiac disease was present several months after the onset of arthritis in 
5.8% of the patients described in the literature 46. Therefore penicillin treatment and long-term 
penicillin prophylaxis have been suggested. The proposed duration of prophylaxis varies 47-50. 
The annual incidence of PSRA in Florida was estimated at 1-2 per 100000 children and 
was twice as frequent as ARF. The mean age was 10 years 49. The arthritis can last from 5 days to 8 
months and some patients continued to have arthralgia for many months after remission. Ahmed et 
al found that PSRA was associated with HLA-DRB*1 46. The term reactive arthritis (ReA) 
has by some authors been used for non-septic arthritis developing after an extra-articular infection 
with one of the so-called arthritogenic bacteria, particularly Chlamydia, Yersinia, Salmonella, 
Shigella or Campylobacter 51, 52. Reiter´s syndrome is a presentation of reactive arthritis defined by 
the triad of arthritis, conjunctivitis, and urethritis (or cervicitis) 52.  
However, the criteria for ReA used in the literature and in clinical practice have ranged 
from a short history of undifferentiated arthritis to criteria such as the 1995 Berlin Third 
International Workshop on ReA, 53, 54 which consist of the presence of a typical peripheral arthritis 
(a predominantly lower limb, asymmetric oligoarthritis) in addition to evidence of a preceding 
infection (either a history of diarrhea or urethritis within the preceding 4 weeks or laboratory 
confirmation of infection with an arthritogenic organism in the absence of clinical symptoms). 
Chlamydia and enterobacteria arthritis seem to be frequent in Norwegian adult 55. Yersinia 
arthritis has been found in Finnish and Italian children with arthritis although the risk of reactive 
arthritis after an entherobacterial infection is probably low 3, 56-58. Most cases of  arthritis following 
gastrointestinal tract infections occur in boys between the ages of 8 and 12 years, but sex and age 
distribution vary according to the causative organism.  
Lyme arthritis was first described by Steere and colleagues in 1977 in a cluster of children 
thought to have JRA in and around Old Lyme, Connecticut, USA 59. The term Lyme borreliosis is 
often used in Europe; Lyme disease is the most frequent term in North America. There is no 
classification criterion for Lyme borreliosis. Laboratory methods to document infection with B. 
burgdorferi include direct tests, such as culture or polymerase chain reaction (PCR) to detect 
borrelia sequences, and indirect tests such as serology.  
In Europe Lyme borreliosis is probably most common in the in central Europe, but occurs 
endemically from Scandinavia to the Mediterranean. In Norway, surveillance was initiated in 1991 
60
. It is most frequently reported in the counties of Vestfold, Telemark, Aust-Agder, Vest-Agder 
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and Rogaland. A study from southern Sweden found an annual incidence of Lyme borreliosis of 69 
per 100 000 (paediatric and adult population). In children Lyme borreliosis was most common in 
patients aged 5-9 years. Lyme arthritis was present in 7% of all cases 61.  
Arthritis may appear months to years after infection 62. Monarthritis of a knee occurs in two 
thirds of children. At onset the arthritis could last for few days, but recurrent episodes, and more 
than 3 months disease duration has been reported in up to one fifth of patients. The American 
Academy of Pediatrics recommends 28 days of antibiotic treatment and additional therapy in case 
of recurrent attacks 50. 
When we started our study there were few reports of the incidence of childhood arthritis 
such as enteropathic, Lyme or PSRA 7, 49, 62.  
The impact of viruses in acute and chronic arthritis is complex, because all children are 
occasionally inflicted by viral microbes. Arthralgia is probably more common than arthritis and 
remission occurs within a few days. Togaviruses (rubella, alphaviruses) account for most cases 63, 
64
. Studies of viral serology in children with chronic arthritis have been hard to interpret.  Do the 
patients have chronic arthritis with concomitant viral infection or is the virus responsible for the 
arthritis? An argument that supported the rubella virus as a potential cause of chronic arthritis was 
the presence of rubella virus in the synovial fluid of several chronic arthritis patients 65. For 
hepatitis B and C, arthritis may result from host cellular or humoral immune responses, while other 
viruses may act indirectly by altering the integrated host defence network, or by inducing frank 
autoimmunity, as with human immunodeficiency virus (HIV) and human T-cell lymphotropic virus 
type 1 (HTLV-1) 63. The association between rubella and other viruses in chronic arthritis remains 
unsolved 64, 66.  
Since the HIV epidemic began, millions of people in sub-Saharan Africa have been 
infected. This is also reflected in departments of Rheumatology. A study from adult patients in 
Congo-Brazzaville showed that 22% of the patients were HIV positive and that 80% of these 
patients had HIV-related arthritis 67.  
Kunnamo found that three children had arthritis associated with a recognised viral 
infection; measles, varicella and adenovirus 3. In another population based Finnish study three 
children had antibodies against Sindbis (Pogosta) virus 8. 
 
Transient arthritis 
The term “transient” arthritis is most known from the idiopathic disorder “transient or toxic 
synovitis of the hip.” It is characterised by short disease duration without a recognised microbe 
although a history of recent-upper airway infection is present in several patients 68. A study that 
compared septic arthritis with transient synovitis of the hip found that septic arthritis could be 
predicted by a history of fever, non-weight-bearing, ESR  40 mm/h and serum WBC > 12x 109 
cells/l 69. The annual incidence rate of transient synovitis of the hip has been estimated from 39 to 
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200 per 100 000 subjects 3, 7, 70, 71. Transient synovitis of the hip is most common in boys aged 3-10 
years. One study showed that ten percent of patients had recurrent attacks within the first two years. 
Legg-Calvé-Perthes, has been reported as long term sequelae 3, 70-72.  
 
Septic arthritis  
Septic arthritis is usually defined as the presence of bacteria in the synovial fluid by Gram´s strain 
or culture, synovial fluid white blood cell (WBC) count  50 X 109/L or in some cases by a positive 
blood culture or culture from other possible sites of infection 3, 69, 73-75. Septic arthritis is a serious 
and potentially life threatening disease that can lead to rapid destruction of the articular hyaline 
cartilage and irreversible loss of joint function 76, 77. It most frequently results from haematogenous 
spread of bacteria, although it can also occur due to local spread from contiguous infection (i.e. 
osteomyelitis), trauma or surgery. Studies have shown that the diagnosis is delayed in 31% to 48% 
of children 78, 79. 
In one study septic arthritis had an annual incidence of 6.7 per 100 000 children 3. An 
increase in the incidence has been suggested, but was not confirmed in another study 80-82. It is 
slightly more common in boys than in girls and is most common in the youngest children 75. In 
neonates group B Streptococci is most common followed by S. aureus. S. aureus remains the most 
common organism in older children, followed by S. pneumonia and S. pyogenes. However, 
Kingella kingae has been reported more frequently in recent studies and H. influenzae has become 
rare in countries where H. influenzae vaccination programs are used 74, 83.  
There is limited data on the incidence of septic arthritis in sub-Saharan Africa, but 
Salmonella was cultured in 40% to 60% of children from series in Zambia, Malawi and Kenya 84-86. 
This is probably linked to the assumption that Salmonella is the most common organism found in 
the blood of sub-Saharan children 87-89. 
The proportion of positive synovial fluid cultures in children diagnosed with septic arthritis 
is reported at 30% to 82%. A positive microbiological finding is often used as a selection factors 
which therefore overestimate the number of culture positive cases. Culture positive and culture 
negative patients have been found to be similar in terms of age, joint involved, synovial fluid WBC 
count and ESR value 75, 82, 90, 91. Possible explanations for negative joint cultures are that pus exerts 
a bacteriostatic effect on microbiological growth,  prior use of antibiotics and  culture techniques 91. 
The joints of the lower extremity (hip, knee, and ankle) are most commonly involved whereas 
septic arthritis affecting the small joints of the hands and feet is rare 80, 90. In a few patients more 
than one joint is infected 82. 
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Childhood osteomyelitis 
Osteomyelitis is an infection of bone that is usually bacterial in origin 92. Osteomyelitis may cause 
growth changes or pathological fractures 93, 94.  It  can be limited to a single portion of the bone or 
can involve several regions, such as marrow, cortex, periosteum, and the surrounding soft-tissue 2, 
95, 96
. A suggested classification of different types of OM is shown in table 297. Haematogenous 
osteomyelitis is most common in children.  
Table 2. Suggested classification of osteomyelitis (OM) 
 
Haematogenous osteomyelitis 
- acute 
- subacute  
- chronic 
 
Exogenous osteomyelitis 
- posttraumatic 
- postoperative 
- contiguous 
 
Osteomyelitis of unknown aetiology (sterile lesions) 
- primary chronic sclerosing 
- chronic recurrent multifocal (CRMO) 
-      SAPHO  syndrome (synovitis, acne, pustulosis, hyperostosis, osteitis) 
 
 
In the metaphysis there are tiny vascular loops in which blood flow is sluggish and oxygen 
tension is low. In the pathogenesis of haematogenous OM there are three main mechanisms. 1) A 
local circulatory disturbance caused by bacterial inflammation (or a minor trauma) leading to 
thrombosis of the sinusoidal vessels; 2) increased pressure in the medullary cavity due to exudation 
and later a polymorphic inflammatory response, producing massive bone necrosis and 3) a 
destructive proteolytic effect of pus 97. 
In the first year of life blood vessels connect the metaphysis and epiphysis so that pus from 
the metaphysis can enter the joint space. In older children the purulent material moves laterally 
through cortical vascular channels and ends up under the periosteum.  
Staphylococcus aureus is the most common microbe followed by S. pyogenes and group B 
streptococcus. Series have shown that the proportion of culture-negative osteomyelitis cases has 
ranged from 15% to 47%. 94, 98 Two retrospective studies have shown a higher proportion of 
negative culture results in children with longer duration of symptoms and older age 94, 98. One study 
comparing culture negative and culture positive patients found that both groups responded similarly 
to treatment and therefore recommended management as presumed S. aureus disease in culture-
negative cases 98. Histology showing pathologic changes is an important asset in subacute and 
chronic osteomyelitis patients 99.  
The incidence of osteomyelitis has been reported from retrospective hospital based studies 
or from national patient registries at 3 to 72 per 100 000. Vertebral osteomyelitis has an annual 
incidence of < .5 per 100 000 or a proportion of 2% of all osteomyelitis cases 94, 100-105. Blyth et al. 
found a reduction of the incidence in Scotland of more than 50% between 1979 and 1997 and an 
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increase in the proportion of patients with subacute osteomyelitis (a history of more than two 
weeks at presentation to hospital). Femur and tibia have been the most frequently affected bones 93, 
102, 103, 105
. Blyth et al. also suggested a lower proportion of patients with long-bone involvement 103. 
Most studies report that osteomyelitis is more frequent in boys than girls, however; this was not 
found in a previous Norwegian study 93, 103, 105.  
According to some authors discitis is inflammation restricted to the disc space and the term 
spondylodiscitis is used where both the disc and the adjacent bone structures are affected. The 
distinction of vertebral disc infection from vertebral osteomyelitis was originally a radiological 
distinction, however, even with modern imaging techniques, there is no accepted basis on which 
how to make such a distinction 106. In children vascular channels penetrate into the nucleus 
pulposus helping bacterial emboli to be deposited within the disc itself. It is thought that the 
abundant intraosseous arterial anastomosis both predispose to an infective agent settling in the disc, 
as well as promoting clearance of microbes and allowing a more rapid resolution of infective 
discitis than that which is observed in adults 107, 108. S. aureus, Enterobacteriaceae and Moraxella 
are the microbes most commonly identified in patients with discitis. Brown et al. do not 
recommend open or needle disc biopsies in young children because of a low rate of positive 
cultures and unknown long-term effect of the procedure. They as well as other authors only suggest 
disc biopsies in the immunocompromised child or those that do not respond to antibiotics 108-110. 
Not all centres routinely prescribe antibiotics 110. However, a retrospective multicentric study 
demonstrated a significant reduction in the duration of symptoms in those treated with iv. 
antibiotics compared with oral or no antibiotics 106.  
 
Identification of arthritis and osteomyelitis patients 
Clinical 
Care of a child with musculoskeletal complains requires time and a complete paediatric 
examination 111. A child with arthritis or osteomyelitis may appear well 12, 103. 
 
Laboratory tests 
No laboratory test can confirm the diagnosis of arthritis, although tests can support the evidence of 
inflammation. Patients with chronic arthritis may have normal values 23. In patients with acute 
osteomyelitis ESR, CRP and WBC are elevated in 92-100%, 82-98% and 35-58% of the cases 
respectively 112, 113. However, acute phase reactants can be normal when bone abscesses are present 
93, 94, 114
. The discriminative ability of laboratory tests to identify osteomyelitis patients in an 
unselected cohort of children with acute onset musculoskeletal features has previously not been 
studied. 
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Plain films 
Plain films use ionising radiation and should be the first step in the imaging assessment of 
osteomyelitis. Plain films can also be used in patients with suspected septic or persistent arthritits. 
They mostly exclude fractures or other orthopaedic conditions and provide landmarks for other 
imaging modalities. The earliest sign in osteomyelitis is the swelling of deep soft-tissue. Bone 
destruction or periosteal reactions are found 10-21 days after the onset of disease 115. Radiographic 
damage in chronic arthritis patients are observed after 6 to 10 years 116. 
 
Ultrasound 
Ultrasound is useful for evaluation of synovitis, joint effusions, tenosynovitis and ganglion cysts 
and guides fluid aspiration. Hip joints and shoulder joints can be difficult to demonstrate clinically 
111, 117
. However, ultrasound is user dependent and requires experience. Although that a normal 
ultrasound can not rule out osteomyelitis findings as deep soft tissue swelling, elevation of 
periosteum by fluid, subperiosteal abcess and costical erosion may support the diagnosis118.  
 
Computed tomography  
Computed tomography (CT) uses ionising radiation and generates a three dimensional image from 
a large series of two dimensional radiographic images. CT can be of use in evaluation of 
osteomyelitis, sacroiliac joints, temporomandibular joints and feet, but is used less frequently after 
the introduction of MRI 12. CT is said to be superior to other imaging modalities in evaluation of 
chronic osteomyelitis patients as it demonstrates cortical erosions and bone sequestration.  It is also 
useful to guide biopsy procedures. 119, 120 
 
Bone scan 
Bone scan could be used if there is doubt about osteomyelitis or the location of a pathological bone 
process. Several types of nuclear imaging modalities exist (e.g. Galluim scan, white blood cell 
scan, immunoglobulin scan). 99mTc methylene diphosphonate (99mTc-MDP) is the most used 
method for identifying osteomyelitis. The standard approach is a three-phase procedure to examine 
perfusion, soft-tissue blood pool and delayed (3 hours) bone uptake. Increased uptake on both sides 
of a joint can provide evidence of arthritis 12.  The intensity of bone uptake becomes more focal at 
the area of interest, and when positive on all three phases, is highly sensitive for osteomyelitis. 
Bone scans are reported to be sensitive in the diagnosis of osteomyelitis (73% to 100%), 121-124 but 
the difficulty in separating bone-marrow processes from soft-tissue disease limits specificity and 
accuracy 125.  
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MRI 
Magnetic resonance imaging (MRI) does not rely on ionising radiation, but on radio waves and 
magnetisation.  The patient is placed in a magnet; a radio wave is sent and then turned off. The 
patient emits a signal which is received and used for reconstruction of the picture. T1 and T2 are 
time parameters that depend on physical and chemical properties that vary with the different tissues 
and are related to the molecule mobility. T1 describes the time required for magnetisation build-up. 
T2 describe the time for transverse relaxation.  
At birth the bone marrow is haematopoietic, during childhood it transforms to fatty tissue 
at different time in the different bones. Normal red marrow show low signal intensity on T1 and 
variable intensity on T2. In contrast normal yellow marrow show high signal intensity on T1 and 
intermediate intensity on T2. MRI shows the overall concentration of fat and water in the marrow 
rather than its histological changes 126. 
 Sequences as STIR (short tau inversion recovery) and T2 fast spin echo can by suppressing 
the signal from fat better bring out and delinate edematous areas with higher signal intensity than 
the surrounding tissue as in osteomyelitis and tumours. The T1 fast spin echo with fat saturation 
will when using MRI contrast media as Gadolineum in the same way bring out and delinate 
contrast enhanced tissue as in inflammation.  
In the acute phase of osteomyelitis, the edema and exudate within the medullary space 
produce an ill-defined low-signal intensity area on the T1-weighted images and a high signal 
intensity area on T2-weighted and STIR sequences. The STIR pulse sequence is said to have a 
negative predictive value for osteomyelitis approaching 100%125, 127, however, conventional T1- 
and T2-weighted images often provide better spatial resolution that better differentiate abscesses 
from circumscribed soft tissue edema.  
 Bone marrow findings of acute osteomyelitis on MRI are non-specific, and clinical 
correlations and risk factor consideration are important to achieve the most correct diagnosis. 
Compared to acute osteomyelitis, subacute and chronic osteomyelitis often shows a relatively sharp 
and better defined interface between normal and abnormal marrow 128. These abscesses may show a 
rim of low signal intensity. The “ rim sign” appears as a low signal intensity rim on T1-wighted SE, 
T2-weighted SE, and STIR  images which correspond to an area of fibrous tissue or reactive bone 
127
. Sensitivity of MRI in the diagnosis of osteomyelitis in adults and children is reported at 88% to 
100% with specificity of 75% to 100% 125, 127, 129-132. In some cases subacute osteomyelitis can be 
difficult to differentiate from bone tumours.  
Contrast enhanced MRI is the most sensitive method to determine whether arthritis is 
present and identify early joint damage. Bony erosions are detected before they are seen on plain 
radiographs 111, 133. 
The disadvantages of MRI are that small children will require general anaesthesia, imaging 
of the whole body is inappropriate, and the examination is time consuming and expensive. In all 
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imaging modalities were contrast fluid is used there is a small risk of life threatening allergic 
reactions.  
As far as we know, MRI has not been used to identify osteomyelitis patients in a large 
prospective population-based study.  
 
Synovial fluid 
Synovial fluid is present in small amounts in a normal joint for lubrication and nutrition. The 
colour is yellow or clear, the WBC count is < .2x109/L and the polymorphonuclear leukocyte 
(PMN) ratio is < 25%. In septic arthritis the fluid is turbid and serosanguineous, the WBC count 
can be 25 to 300 x109/L and the PMN ratio > 75%. The proportion of positive synovial fluid 
cultures varies in patients with septic arthritis (79-36%). A Gram strain can be positive in up to 
50% of previously untreated cases 80, 82, 134. In JIA patients the WBC count can be 15 to 20 
x109/L 12. 
 
Bone biopsy 
If bone biopsy is assessed in patients with suspected osteomyelitis both histological and 
microbiological samples should be taken due to the low proportion of positive cultures (40-87%) 93, 
135, 136
. Prior use of antibiotics, small tissue volumes and sampling errors may be explanations for 
culture negative results. Histology may show acute inflammatory cells, congestion of small vessels 
and necrosis. In chronic osteomyelitis patients there can be high numbers of lymphocytes, 
histiocytes and plasma cells in the absence of neutrophils 137. 
Tissue sampling can be obtained with open surgical biopsy as the golden standard or by 
fine-needle aspiration (FNA) or core-needle biopsy.  The size and number of specimens that should 
be obtained for histopathology are not known 138, 139.   
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AIMS OF THE STUDY 
The overall aim of this study was to estimate the annual incidence of arthritis and osteomyelitis in 
children, to describe the role of patient characteristics, joint involvement, auto-antibodies, HLA-
B27 and microbiological variables in early recognition of subgroups of arthritis patients and 
evaluate features that identify osteomyelitis patients.   
 
Within this our aims were: 
I We wanted to estimate the annual incidence rate of arthritis in children in urban and non-
urban counties and describe the role of patient characteristics, auto-antibodies, HLA-B27, 
and microbiological variables in early recognition of distinct subgroups of childhood 
arthritis (paper I). 
 
II  We wanted to investigate the frequency of S. pyogenes in a cohort of children with recent-
onset arthritis. We wanted to compare the characteristics and early disease course of PSRA 
patients with those of transient arthritis and juvenile idiopathic arthritis (JIA) and describe 
the role of patient characteristics, disease duration, auto antibodies and HLA-B27 in the 
early identification of PSRA. We also wanted to report the occurrence of cardiac 
involvement during the first 18 months of disease duration in patients with ARF and PSRA 
(paper II).  
 
III We aimed to assess the annual incidence rate of different types of osteomyelitis in children 
and compare the patient and laboratory characteristics in osteomyelitis with that of patients 
who had other acute onset musculoskeletal features. In addition, we wanted to compare the 
patient, clinical, microbiological and MRI characteristics of children with acute- and 
subacute osteomyelitis (paper III). 
 
IV We wanted to determine the predictive value of patient characteristics, disease variables 
and routine laboratory features in separating patients with JIA from other types of recent-
onset arthritis on an early stage (paper IV). 
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MATERIALS AND METHODS 
Study design 
Our study is a prospective and partly retrospective population-based study of a cohort of patients 
with acute onset musculoskeletal features who live in the counties Oslo, Akershus and Buskerud. 
The patients were examined on admission, after six weeks, six months and thereafter as long as 
clinically needed. Patients with PSRA were also examined after 18 months (paper II).  
 
Patients 
Patients were recruited from primary care physicians, pediatricians, orthopaedic surgeons and 
rheumatologists in the counties of Oslo, Akershus and Buskerud. They received four letters: one at the 
beginning and then every 3 months during the study period. The letters included the recruitment 
criteria, the referral process to have the patient admitted within one to three days, and informed about 
arthritis and osteomyelitis in children as well as the objectives of the study. Furthermore, the 
physicians at the hospitals and at emergency wards were informed through meetings. Patients < 16 
years of age with residence in the counties were admitted at one of the paediatric departments in the 
region or at the regional department of rheumatology (i.e. at Akershus University Hospital, Buskerud 
Hospital, Ullevål University Hospital or Rikshospitalet Medical Centre). The total number of patients 
in the region was 255 303 on January 1, 2004 140. The recruitment period was from 1 May 2004 to 30 
June 2005. At the end of the study, we searched the hospitals’ computerized records for 181 relevant 
diagnoses [based on the International Classification of Diseases, 10th edition (ICD 10)] 141 to identify 
any patients who met the recruitment criteria but had not been included. The last patient data was 
collected in May 2007.  
 
Recruitment criteria 
The recruitment criteria were patients with possible or evident arthritis and/or osteomyelitis, 
determined on the basis of  1 or more of the following characteristics: (1) joint swelling; (2) 
limited range of motion in  1 joint, or walking with a limp or other functional limitations affecting 
arms and/or legs; and (3) pain in  1 joint or extremity together with C-reactive protein (CRP) level 
of > 20mg/L and/or erythrocyte sedimentation rate (ESR) >20mm/hour and/or white blood cell 
(WBC) count of >12x109/L. These signs should have lasted for < 6 weeks and should not have 
been caused by trauma.  
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Inclusion criteria 
The inclusion criteria for arthritis patients were one of the following three signs: (1) swelling of a 
joint; (2) restricted mobility of a joint with warmth and/or tenderness and/or pain1; or (3) arthritis 
demonstrated by ultrasound or magnetic resonance imaging (MRI). 
The inclusion criteria for osteomyelitis patients were characteristic signs and symptoms of 
bone infection and one of the following: (1) positive culture from bone biopsy and/or histology 
showing inflammation; (2) MRI findings consistent with osteomyelitis; and (3) positive bone scan 
if bone biopsy and/or MRI were not done.  A flowchart showing the patients included in the 
different papers is presented in figure 1. 
 
  
Exclusion criteria 
Patients who had sickle cell anaemia, malignant disease or had been diagnosed with JIA before 1 
May 2004 were excluded. In addition patients who had inflamed synovia related to trauma were 
excluded.  
 
Non participants 
In paper II and III there were 9-20% non-participants due to incomplete data. The non-participants 
were comparable to the participants as regards age, sex and duration of symptoms. We do not know 
whether any primary care physicians refused to refer patients to our study.  
 
484 had 
possible 
arthritis and/or 
osteomyelitis 
434 included 
in papers 
429 (III) 
- 37 OM 
- 205 arthritis 
- 187 other 
50 excluded 
213 had no arthritis 
221 total arthritis 
- 5 not blood test 
- 11 arthritis and OM 
- 205 arthritis 
 
5 arthritis,  
no blood test 
182 arthritis 
(I), 12 months 
 
and 
 
39 arthritis 
(May 04 and 
June 05) 
7 not included 
- 1 SLE 
- 2 mixed 
- 4 classified after 
reevaluation of MRI 
214 arthritis 
(IV) 
173 arthritis  
(II) 
41 not tested for 
S. Pyogenes 
Figure 1. Flowchart showing the patients included in the different papers.  In paper I the patients were included between June 
2004 and May 2005. In paper II-IV the patients were included between May 2004 and June 2005. In paper III patients without 
arthritis and/or osteomyelitis were also included. In that paper the MRIs were evaluated by two radiologists blinded to clinical 
information. Roman numbers refers to number of paper. OM = osteomyelitis, MRI = magnetic resonance imaging, SLE = systemic 
l h
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Follow-up 
In paper III 40-61% of the patients without osteomyelitis did not receive follow-up at six weeks or 
six months (table 3). According to the hospital medical charts, these patients did not have further 
symptoms of arthritis or osteomyelitis. In paper I 20% of the arthritis patients did not attend the six 
weeks follow-up visit and 39% did not attend the six month follow-up visit. Our impression was 
that parents of arthritis patients who went into remission within few days after the onset of 
symptoms were less willing to attend the planned follow-up visits.  
 
Table 3. Follow-up of the patients in the different papers* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* patients with persistent signs or symptoms received up to three years of  follow-up 
OM = osteomyelitis; JIA = juvenile idiopathic arthritis; PSRA = poststreptococcal reactive arthritis  
 
Clinical data 
Clinical information was obtained by medical record reviews and physical examination. The 
number of swollen, tender and mobility restricted joints was registered at each visit. Most arthritis 
and osteomyelitis patients were examined by one of two physicians (ØR, KH) at six weeks and six 
months and in addition most patients with JIA were examined by a consultant in paediatric 
rheumatology (BF).  
  
Laboratory data 
Hemoglobin, WBC with differential, platelet count, ESR, CRP, culturing of throat swab and feces 
were measured by standard methods. Serologic examinations were assessed by the methods in use 
at each hospital i.e. antistreptolysin-O (ASO), anti-deoxyribonuclease B (anti-DNAse B), Hepatitis 
B, Mycoplasma pneumoniae, Chlamydia, Epstein-Barr, Cytomegalovirus, Parvovirus B19, 
Yersinia enterocolitica, Borrelia burgdorfe. Antinuclear antibody (ANA) was measured by 
fluorescence or ELISA, anti-cyclic citrullinated peptide antibody (anti-CCP) by ELISA, IgM RF by 
ELISA or immunonephelometry and HLA-B27 by flowcytometry, serology or genetic methods. 
One ANA titre of 40 or a ratio of >1.4 was considered positive. In addition anti-CCP level of 25 
U, >5 IU/ml, or RF of 24.0 IU/ml was considered positive. 
Paper No. of 
patients 
 
Follow-up 
6 weeks (%) 
Follow-up 
6 months 
(%) 
Follow-up 
18 months 
(%) 
Paper I 182 80 61 NA 
Paper II 173 87 69 90 (PSRA) 
Paper III            -      OM 
                          -      not OM 
429 
 
97 
60 
89 
39 
NA 
Paper IV 
- JIA 
- Infectious 
- Transient/post-
infectious 
214   
100 
 93 
 73 
 
98 
93 
50 
 
NA 
NA 
NA 
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Joint aspiration was recommended within three days if mono- or oligoarthritis of < 2 
weeks’ duration occurred in combination with one of the following four: 1. fever > 38.5º C, 2. CRP 
> 30 mg/L or ESR >30 mm/hr or WBC > 12x109/L, 3. excessively painful joint or bone, 4. other 
suspicious factors for septic arthritis or osteomyelitis. In addition we recommended that joint 
aspiration should be performed within 14 days if arthritis in one to three joints persisted for more 
than one week. In paper I the classification criterion for septic arthritis was that either the synovial 
fluid was positive for bacteria by culture or microscopy, or the synovial fluid WBC count was > 
50x 109/L. In paper IV a positive blood culture also classified for septic arthritis.  
 
Radiological examinations 
Standard radiographs of the affected area were obtained in all patients by conventional technology 
except for patients with transient synovitis of the hip with disease duration of less than one week. 
An ultrasound of affected joints was performed on admission. In addition an ultrasound of 
the hips was performed on all of the children <5 years of age with symptoms from the legs.  
 Three-phase bone scan (99Tc methylene diphosphonate) was recommended if there was 
doubt about the localisation of the arthritis/osteomyelitis.  
MRI was recommended within 3 days if mono- or oligoarthritis of < 2 weeks’ duration 
occurred in combination with one of the following four: 1. fever > 38.5ºC; 2. CRP > 30 mg/L or 
ESR >30 mm/hr or WBC > 12x109/L; 3. excessively painful joint or bone; 4. other suspicious 
factors for osteomyelitis or septic arthritis. We also recommended that MRI should be performed 
within 14 days if arthritis persisted for more than one week in one to three joints.  
In paper I, II and IV we used the standard descriptions from the radiologists as diagnostic 
tools. However, in paper III two experienced radiologists retrospectively evaluated the MRIs, 
blinded to all clinical information except for the patient’s age and that there was clinical suspicion 
of osteomyelitis. The MRI findings were presented by consensus.  
In cases of bone marrow edema, subacute osteomyelitis was defined as well-circumscribed 
lesions with homogeneous or peripheral contrast enhancement, periosteal inflammation, fibrosis, 
fistula or sequester. Acute osteomyelitis was defined as a poor interface between the normal and 
diseased bone marrow.  The radiologists also reported the presence of arthritis in a nearby joint, 
other soft tissue abnormalities, and other orthopaedic conditions.  
The MRIs were performed in different machines in different hospitals (1.0T or 1.5T). The 
MRI examinations had at least one T1 spin echo sequence and one STIR (Short T1 Inversion 
Recovery) sequence. In most cases (and in every case with well circumscribed lesions), there was 
also at least one contrast-enhanced T1 spin echo sequence. 
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One of the radiologists was then informed of the final diagnosis, and evaluated the follow-
up plane radiographs and/or MRIs of the osteomyelitis patients in order to report the presence of 
any remaining signs or sequelae.  
 
Classification of patients  
Two researchers (ØR, KH) recorded the clinical information on a standardised form. In case of 
disagreement, the classification was established in consultation with specialists in paediatric 
infectious diseases (KOW) and paediatric rheumatology (BF). 
In paper I we presented all the microbiological data available from admission and at six 
weeks follow-up when we classified the arthritis patients. However, when we focused on the 
presence of S. pyogenes (paper II) we focused on data from admission and 5 PSRA patients were 
reclassified to transient arthritis (these patients did not have carditis after 18 months). This was 
done to increase the likelihood of an association between presence of S. pyogenes and arthritis.  
The arthritis would probably be present 2-4 weeks after infection with S. pyogenes and the 
antibodies would reach their maximum at the time of the onset of arthritis or shortly thereafter 
(ASO maximum 3-6 weeks after infection with S. pyogenes and anti-DNAse B maximum 4-8 
weeks after infection with S. pyogenes) 4. If this is the case, the convalescent serum samples would 
probably not show elevated titres six weeks after the onset of arthritis (8-10 weeks after the 
estimated infection with S. pyogenes). We also changed the anti-DNAse cut-off titre from 600 
IU/ml (paper I) to 800 IU/ml in paper II. This was done because anti-DNAse may stay elevated 
for many months after a streptococcal infection, and because the cut-off titre chosen in paper I was 
lower than in most other papers on PSRA 32, 43, 48, 142, 143. 
We used MRI as one of the diagnostic tools for identification of arthritis or osteomyelitis 
patients in all papers. Four patients were reclassified into osteomyelitis in paper III as radiologists 
retrospectively evaluated the MRIs. In paper I, II and IV we used the routine description from the 
hospitals´ radiologists.   
One patient who was classified as JIA in paper I, II and III was excluded in paper IV due to 
reclassification to SLE. One patient was classified as transient arthritis in paper I, II and III, but 
was excluded in paper IV due to recurrent fever, highly elevated CRP (415 mg/L) and possible 
pneumonia or pyelonephritis. One patient with post-infectious arthritis was regrettably missing in 
paper IV. 
 
Ethics 
Written informed consent was obtained from the parents of the children included in the study. 
Children aged more than 12 years received a simplified information letter. The Regional Ethics 
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Committee for Medical Research and the Ombudsman for Privacy in Research at the Norwegian 
Social Science Data Services approved the study.  
 
Statistics 
All of the analyses were performed by using SPSS 13,14 and 15 for Microsoft Windows (SPSS Inc, 
Chicago, IL). P-values < .05 were considered statistically significant, except for multiple 
comparisons in paper III (p < .01).  
Relations between categorical variables were studied using the chi-square test or Fisher´s 
exact test, for groups composed of < 5 case subjects. Differences between groups for continuous 
variables were tested using independent samples t-test when variables were normally distributed. 
For not normally distributed continuous variables we used the Mann-Whitney-Wilcoxon test for 
comparison between two groups and the Kruskal-Wallis test for comparison between multiple 
groups. The continuous variables were described in terms of range, medians and quartiles. We 
constructed 95% confidence intervals for incidence using the normal distribution approximation 
(paper I). 
Two multiple logistic regression models were fitted in order to investigate whether hip 
arthritis and active disease at six weeks were independently associated with PSRA versus JIA, and 
whether age and active disease at six weeks were independent predictors of PSRA versus transient 
arthritis (paper II). Sensitivity was defined in terms of the proportion of positives correctly 
identified by the test. Specificity was defined in terms of the proportion of negatives correctly 
identified by the test. Positive predictive value was defined in terms of the proportion of patients 
with positive test results who were correctly diagnosed. Negative predictive value was defined as 
the proportion of patients with negative test results who were correctly diagnosed (paper II and III).  
The sensitivities and specificities of the laboratory tests used to discriminate between 
patients with and without osteomyelitis were presented graphically using ROC curves. The area 
under the ROC curve (ROC AUC) provides a measure of the overall discriminative ability of the 
test. AUC equals .5 when the ROC curve corresponds to random chance and 1.0 when there is 
perfect accuracy (paper III). 
Logistic regression (Binary logistic) analyses with JIA-diagnosis as the dependent variable 
were used to identify predictors of JIA (paper IV). Initially, potential predictors of JIA were tested 
in a univariate model. Continuous variables (except for age) were dichotomized to categorical 
variables in order to give them a more meaningful value in a clinical setting. This applied to 
duration of symptoms (cut-off 14 days), temperature (cut-off 38.0 degrees Celsius), neutrophile 
WBC-count (cut-off 6.0 x 109/L) and platelet-count (cut-off 390 x 1012/L). The cut-off values for 
the blood tests were based on normal values in our labs.  
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Variables associated with JIA  (p-values below 0.10) in the univariate analysis were 
analysed as possible predictors in the subsequent multivariate analyses except for total WBC-count 
that was not included due to a high correlation with neutrophile WBC-count (Pearson correlation 
0.8, p=0.01) and polyarthritis that was excluded due to high correlation with small-joint 
involvement (Pearson-correlation 0.54, p=0.01). Furthermore, HLA-B-27 and ANA were excluded 
in the multivariate analyses due to a high percentage of missing values.  
When identifying determinants that differentiated the JIA-group from the infectious 
arthritis group, the numbers of independent variables included in the multivariate analysis were 
limited due to the low number of patients. We chose two variables for joint distribution (hip and 
knee), one clinical (fever), one laboratory-variable (neutrophile WBC-count) and one symptom-
variable (duration of symptoms) in addition to age and gender.  
In the multivariable regression analyses the missing values were replaced with mean values 
when data were symmetrically distributed and median values when not. Five variables had missing 
values, ranging from 2.3% to 11.7%.  
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SUMMARY OF RESULTS 
Paper I  
Incidence and Characteristics of Arthritis in Norwegian Children: A 
population-Based Study  
We wanted to assess the annual incidence rate of arthritis in children and describe early disease and 
patient characteristics, microbiological features, and immunogenic factors in children with different 
subgroups of childhood arthritis. Physicians were asked to refer their patients with suspected 
arthritis and the patients were assessed on the basis of clinical, radiological and laboratory 
examinations at inclusion and followed-up at six weeks and six months. 
We found a total annual incidence of 71 per 100 000 children. Arthritis was more common 
in patients younger than 8 years of age and more common in boys than girls under 8 years of age. 
Transient arthritis was by far the most frequent subgroup, followed by JIA, post-infectious arthritis 
and infectious arthritis. Children with septic arthritis were younger (median 1.9 years) than those in 
the other groups and patients with post-infectious arthritis had the highest age of onset (median 7 
years). JIA was associated with female gender, polyarthritis, small joint arthritis, absence of hip 
joint arthritis, ANA, anti-CCP, IgM RF and HLA-B27. PSRA was found in 10% of patients, while 
arthritis associated with enteropathic bacteria was found in two patients. Eight patients tested 
positive on viral antibodies. Viral antibodies were found in all diagnostic groups. Three patients 
had Lyme arthritis. 
 
Paper II  
Recent-onset childhood arthritis-association with Streptococcus pyogenes 
in a population-based study 
In this study we wanted to assess the frequency of signs of Streptococcus pyogenes in children with 
early arthritis, compare the characteristics in patients with post-streptococcal ReA (PSRA) with 
those in patients with other types of arthritis, and describe the occurrence of carditis in PSRA and 
ARF. A total of 173 arthritis patients were tested for the presence of S.pyogenes.  The PSRA 
patients were examined by a paediatric cardiologist at 18 months.  
The percentage of positive streptococcal tests correlated with the age of the child and was 
found in 35 % of the arthritis patients aged eight to 11 years.  Patients with PSRA were older and 
had a longer disease duration than those with transient arthritis. Hip involvement, inactive disease 
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at six weeks and six months and negative ANA and HLA-B27 were more frequent in PSRA than in 
the JIA patients. One third of the patients with PSRA still had signs of streptococcal infection after 
18 months. Carditis was only found in one child, who had ARF.  
 
 
Paper III  
Childhood osteomyelitis- Incidence and differentiation from other acute 
onset musculoskeletal features in a population-based study. 
The aim of this study was to assess the annual incidence of osteomyelitis in children, describe the 
patient and disease characteristics in those with acute (< 14 days disease duration) and subacute 
osteomyelitis ( 14 days disease duration), and differentiate osteomyelitis patients from those with 
other acute onset musculoskeletal features.  
Of the eligible patients 37 had osteomyelitis (11 also had arthritis), 7 had septic arthritis 
without osteomyelitis, 19 had skin infection, 198 had non-infectious arthritis (109 transient, 40 JIA, 
28 post-infectious, 20 vasculitis, 1 SLE) and 168 had other conditions. 
We found a total annual incidence rate of osteomyelitis in children of 13 per 100 000. 
Thirty-five percent had subacute osteomyelitis. Osteomyelitis was most common in patients under 
3 years of age. ESR was the best laboratory test for identifying osteomyelitis patients, but the 
highest positive predictive value was only 26%. The most frequent bone involvements were the 
long bones. Vertebral osteomyelitis was common (24%). Blood cultures were negative for all 
patients with subacute osteomyelitis and only positive for 26% of patients with acute osteomyelitis. 
The temperature and the laboratory test results were higher for patients with acute osteomyelitis 
than for patients with subacute osteomyelitis. In addition, subacute MRI signs were present in 69% 
of osteomyelitis patients with more than 14 days` disease duration.  
 
Paper IV  
Predictors of Juvenile Idiopathic Arthritis in a population-based cohort 
of children with very early arthritis 
We wanted to assess the ability of patient characteristics, disease variables and laboratory variables 
to predict the diagnosis of juvenile idiopathic arthritis (JIA).  The diagnostic outcomes of 214 
patients were obtained by chart reviews after two years.  
In the present study, predictors of the evolution of JIA in very early childhood arthritis 
were small-joint involvement, symptom duration for more than two weeks, a neutrophile WBC-
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count in the normal range, knee-joint involvement and a platelet-count above the normal limit. The 
same determinants discriminate between JIA and transient/postinfectious arthritis. Determinants 
that discriminate JIA from infectious arthritis are the absence of fever and a low occurrence of hip-
joint involvement.  
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DISCUSSION 
Methods 
General aspects on study design 
The strength of this study is that it is prospective and population-based. In Norway the majority of 
patients receive care in their county of residence, and the homogeneous health care and social security 
system based on equality of access facilitates recruitment to epidemiological studies 144.  
First a group of patients with possible arthritis and/or osteomyelitis was identified. On 
hospital admission physicians could rule out other diagnoses assisted by radiological methods.  
This was done to estimate the annual incidence and to obtain a representative cohort. Then the 
patients were followed for six months (and in some cases up to three years) and the cohort was 
subdivided into groups with different characteristics. This type of research design can be called an 
observational, prospective and longitudinal study design. This design is frequently used to 
investigate prognosis, the natural history of disease and to investigate possible associations 
between factors and a particular condition 145.  
We had a small number of patients with septic arthritis which made a meaningful statistical 
comparison with that group difficult. By only using hospital patient registries we would have had 
larger number of patients and we could have been able to follow incidence rates for many years, 
however the problem of correct ICD coding of patients, variation in laboratory and radiological 
assessments and selection of patients would have limited the interpretation of the results.   
The impact of positive microbiological test in our arthritis patients is uncertain as we did 
not compare with healthy controls. In addition different laboratory test methods were used in the 
different hospitals. Based on our design we could not test whether patients with S. pyogenes 
infection were more likely to have arthritis.  
 
Selection of patients 
An important question is whether we did identify all patients with recent onset arthritis and/or 
osteomyelitis.  We believe that our recruitment criteria included the most common signs and 
symptoms. Maybe however, we ought to have added the term “back-pain” as this can be a 
symptom in older children with sacroiliitis, pelvic osteomyelitis and vertebral osteomyelitis. In 
addition the term “not cause by trauma” could have been unclear to some physicians. On one hand 
a trauma can precede and play an important role in the pathogenesis of osteomyelitis.  In addition a 
child with knee arthritis could fall and the parents would first observe the swollen knee after the 
minor trauma. On the other hand we wanted to avoid including patients with larger injuries or 
fractures. Nevertheless, on admission we never excluded patients due to a history of trauma. Due to 
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our recruitment criteria we also might have missed patients with > 6 weeks disease duration. This 
criterion was set to support early referral of patients with musculoskeletal signs and symptoms. 
A limitation of our design is that we do not know if all primary care physicians participated 
in the study. This is supported by the fact that some patients had seen several physicians before 
admission. In addition the incidence rate of arthritis was higher in the city of Oslo than in other 
counties (although the incidence of JIA was similar) which suggests that not all mild cases were 
referred from areas where the distance to hospitals was longer. It is also possible that some patients 
could have been seen at alternative facilities such as Chiropractors. However, we believe that most 
patients were admitted as we sent several letters to primary care physicians and because of easy 
access to free of charge hospital care.  In very mild cases the parents might not have searched for 
any help.  
We believe that our arthritis and osteomyelitis patients are representative for South-eastern 
Norway. Approximately 25% of Norwegian children live in the study area; however, there could be 
regional variations in Norway. Overall few patients with arthritis (15%) or osteomyelitis (0%) were 
identified by chart review and therefore we had a high success rate in identifying arthritis and 
osteomyelitis patients upon admission. In many cases patients who were identified retrospectively 
were also able to attend the planned follow-up visits.  
 
Loss to follow-up 
We put a great effort in avoiding loss of follow-up. At six months the attendance rate was at 98-
39%. Parents were repeatedly requested to attend the six weeks and six months visits and were 
offered new and flexible schedules if they were unable to attend the planned visits. Two patients 
moved out of our region. Our main impression was that loss of follow-up was due to lost interest as 
the patients had no further signs or symptoms. 
 
Variety in examinations and treatment 
An important research problem was that not all patients were investigated equally closely. Patients 
who appeared ill or were believed to have a chronic disease had more tests, received treatment on 
an individual basis and also had additional follow-up. Due to our study design which included 
ethical aspects we did not suggest MRI and tissue cultures in all patients. Many of our patients 
were young and required general anaesthesia for such procedures. Nevertheless, we believe that the 
number of patients who received an MRI was high (127 patients). There were difficulties in 
performing blood tests and to receive enough blood from all patients. We prioritised blood tests 
which would have a direct impact on the treatment of the patients and this may explain why few 
patients were tested for e.g. HLA-B27. Patients who were not willing to have blood tests or 
radiological examinations were not excluded from our study. 
 
 38
Inter-rater reliability 
In order to identify arthritis patients with rapid remission many children were first seen by the 
paediatrician or rheumatologist on call. Inter-rater reliability for the assessment was not tested and 
variability between the observers may have influenced our results, especially in patients with early 
remission. 
 
Classification of the patients 
We classified patients with JIA according to the ILAR criteria and patients with Acute Rheumatic 
fever (ARF) according to the revised Jones criteria. There are no established classification criteria 
for osteomyelitis or for other subgroups of arthritis. According to the ILAR criteria, the arthritis 
must persist for at least six weeks with exclusion of other well defined diseases; however there are 
reports that patients with entheropathic arthritis or PSRA may have a disease duration of more than 
six weeks 23, 46. When can a patient with persistent arthritis who test positive for microbes be 
classified as JIA? Could this be done after six weeks, six months, two years or ever? The role of S. 
pyogenes in patients with JIA remains uncertain. 146 
 
Results 
Incidence  
We found a total annual incidence rate of childhood arthritis of 71 per 100 000 and of osteomyelitis 
of 13 per 100 000. A higher incidence of arthritis, 109 per 100 000, was found in a similar study of 
Urban Finnish children by Kunnamo et al (1986) 3, 7, 8 (table 4). A comparison between Kunnamos 
and our study (paper I) is shown in table 5. 
 
Table 4. Annual incidence of recent-onset arthritis in children in population-based studies 
 
Author (ref) Location Method n Incidence 
100 000/yr 
Incidence of different types 
of arthritis 100 000/yr 
JIA/JRA    Transient   Septic 
Post-
infectious 
Proportion 
JIA/JCA 
Riise et al, 2008 
(I) 
Norway1 Clinical 182 71 14 43 3 9 20% 
Kunnamo et al, 
1986 (3) 
Finland2 Clinical 161 109 19 78 7 53 17% 
Von Koskull et al, 
2001 (7) 
Germany4 Questionnaire 319 83 7 76 NA NA 8% 
Savolainen et al, 
2003 (8) 
Finland5 clinical 11 64 23 23 NA 176 36% 
 
1
 Oslo, Akershus and Buskerud; 2 Helsinki; 3 Entheropathic; 4 Bavaria, cities; 5Kuopio; 6Sindbis virus 
NA = not assessed  
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Table 5. Comparison of studies on the incidence of childhood arthritis 
 
 Riise et al, 2008 (I) Kunnamo et al, 1986 (3) 
 
Number of patients 182 161 
Age, median, years 4.9 NA 
Female, % 38 42 
Recruitment period June 1, 2004-May 31 2005 May 1, 1982- April 30, 1983 
Recruitment area Eastern Norway,1/3 urban, 2/3 
commuter/rural 
Grater Helsinki, urban 
Referral criteria 1) Joint swelling or 
2) Limited range of motion in  1 joint 
or walking with a limp or other 
functional limitations affecting arms 
and/or legs or 
3) Pain in  1 joint or extremity 
together with elevated CRP, ESR or 
WBC 
 
Swelling or limitation of motion of a joint or walking 
with a limp or hip pain 
Definition of arthritis 1) Swelling of a joint 
2) Restricted mobility of a joint with 
warmth and/or tenderness and/or 
pain 
3) Arthritis demonstrated by 
ultrasound or MRI 
1) Swelling of a joint or 
2) Limitation of motion with heat, pain or 
tendreness 
Follow-up 6 weeks, 6 months,  
additional follow-up data 9-21 months 
2 weeks, 3 months, 
 additional follow-up data minimum 24 months 
Microbiological studies Yersinia, Borrelia, EBV, CMV, 
Chlamydia, mycoplasma, parvovirus 
B19, Hepatitis B, ASO, antiDNAseB, 
throat streptococcal smear, bacterial 
culture of feces, adeno and rota  from 
feces 
Yersinia, Salmonella, Campylobacter, 
Mycolpasma, Chlamydia, Toxoplasma, rubella, 
EBV, ASO, antistreptordornase, throat 
streptococcal smear, virus isolation from feces, 
parasite examination of feces 
Duration of symptoms before 
inclusion 
3 days, median 71% seen within one week 
Annual incidence per 100 000 71; (88 Oslo, 70 Akershus, 44 
Buskerud) 
109 
-Chronic arthritis, (%) 14 (20) 19 (17) 
-Septic arthritis,(%) 3 (4)1 7 (6)2 
-Post infectious, (%) 9 (13) 5 (5)3 
-Transient, (%) 43 (60) 78 (71) 
Viral arthritis 4 CMV, 3 rotavirus, 2 EBV, 1 
mycoplasma, 1 varicella 
1 measles, 1 varicella, 1 adenovirus 
 
 
 
1
 1 S.aureus, 1 Kingella kingae, 1 S. pyogenes, 1 GBS, 1 S. pneumoniae (3 microbes not identified); 2 5 S. aureus, 5 
Hemophilus Influenzae;  
3
 enteropathic  
 
 
In contrast to Kunnamo we did not ask for patients with hip pain as the only symptom, we included 
non-urban patients who had a lower incidence of arthritis compared to urban patients and we had 
less septic arthritis than in Kunnamo´s study which is probably linked to the introduction of 
vaccination against Haemophilus Influenzae.  We did not have any patient with Yersinia 
enterocolitica arthritis. Yersinia arthritis has been reported in several Finnish studies and both 
genetic and environmental differences could explain this finding 57. 
Our incidence of JIA at 14 per 100 000 was similar to other Nordic studies, although the 
incidence has been reported higher (19-23 per 100 000) in Northern- and Middle Norway and in 
Finland 3, 7, 14-18, 147-151 (table 6). 
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Table 6. Incidence of chronic arthritis in European children 
 
Author (ref) Method Location Term Annual 
incidence/ 
100 000 
  Nordic countries   
Moe et al, 1998 (15) Hospital, retrospective Norway, north JCA1 23 
Berntson et al, 2003 (14) Population, 
prospective 
Norway, north 
Norway middle 
JIA2 19 
23 
Riise et al, 2008 (I) Population, 
prospective 
Norway, east JIA3 14 
Gare et al, 1992 (16) Population, 
prospective 
Sweden, west JCA1 11 
Berntson et al, 2003 (14) Population, 
prospective 
Sweden 
Denmark, east 
Denmark, Århus 
JIA2 15 
9 
16 
Kunnamo et al, 1986 (3) Population, 
prospective 
Finland, Helsinki JRA 19 
Kaipiainen et al, 1996 (147) Register, prospective Finland JRA 14 
Kaipiainen et al, 2001 (149) Register, prospective Finland JRA 20 
Berntson et al, 2003 (14) Population, 
prospective 
Finland, Helsinki JIA 21 
Ôstergaard et al, 1998 (148) General clinics, 
retrospective 
Denmark JRA 6-8 
  Other countries   
Pruunsild et al, 2007 (150) Population, 
prospective 
Estonia JIA 22 
von Koskull et at, 2001 (7) Population, 
prospective, 
questionnaire 
Germany, south JCA 6.6 
Kiessling et al, 1998 (18) Hospital, retrospective Germany, Berlin JCA4 3.5 
Symmons et al, 1996 (151) Register, prospective UK, Liverpool JCA 10 
Prieur et al, 1987 (17) Practitioner survey, 
retrospective 
France JCA 1.3-1.9 
 
1
 arthritis not defined; 2 warm and painful joint(s) included in definition of arthritis ; 3 arthritis= swelling of a joint or restricted 
mobility of a joint with warmth and/or tenderness and/or pain.4 not SpA, PsA or IBD 
 
A similar incidence rate of osteomyelitis was found in Tromsø, Northern Norway, at 10 per 
100 000 (1965-1994) and in Lithuania at 11-14 per 100 000 (1982-2003). The significant reduction 
in Scotland over the past 30 years is probably due to methodology 94, 100-104, 152 (table 7). More large 
prospective studies with homogenous assessments and classification criteria are necessary to 
conclude whether there are true changes in the incidence of arthritis and osteomyelitis over time or 
between geographical areas. 
 
Table 7. Incidence of osteomyelitis in children 
 
Author (ref) Method Location Period Annual incidence  
100 000/yr 
Riise et al, 2008 (III) Prospective, 
population 
Norway, east 2004-05 13 (8 acute; 
5 subacute) 
Dahl et al, 1998 (102) Retrospective, 
hospital 
Norway, north 1965-94 8-12 (7% vertebral) 
Craigen et al, 1992 (94) Retrospective, 
hospital 
Scotland 1970-90 9-4 
Blyth et al, 2001 (103) Retrospective, 
hospital1 
Scotland 1990-97 7-3 ( 5-2 acute;  
3 subacute) 
Malcius et al, 2005 (152) Retrospective, 
hospital2 
Lithuania 1982-03 12-14 (acute) 
Gillespie et al, 1979 (104) Retrospective, 
register 
New Zealand 1978-82 10 (European)  
74 (Maori) 
Krogsgaard et al, 1998 
(100) 
Retrospective, 
national register 
Denmark 1991-93 0.4 (only vertebral, 
aged 0-9 yr) 
Grammatico et al, 2007 
(101) 
Retrospective, 
national register 
France 2002-03 0.3 (only vertebral, 
aged 0-20 yr) 
 
1
 spine and skull excluded; 2 local pain and fever mandatory 
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In our study septic arthritis and osteomyelitis was most frequent in children < 3 years of 
age and in line with others the age distribution of JIA tends to be bimodal with higher incidence 
rates in children aged 1-3 years and in children aged 9-15 years 14, 16, 21. Hence, patients < 3 years of 
age should be examined for these diseases.  
 
Bones and joints 
In our study knee joint arthritis was as common as hip joint arthritis followed by ankle joint 
arthritis. However, very high numbers of patients with transient synovitis of the hip have been 
reported in the literature 3, 7, 70, 71. 
The finding of a low proportion of long bone involvement in our (paper III) and newer 
studies was different from older studies and a study from South Africa 93, 99, 102, 112, 153, 154. This could 
be linked to improved standards of living and hygiene.   
In line with other studies we found osteomyelitis to be most frequent in the lower 
extremities. On the other hand we found a high proportion of patients with vertebral osteomyelitis 
(24%) compared to most previous studies 93, 99-101. Such cases have also been diagnosed as 
spondylarthritis, spondylodiscitis or discitis and there are no verified classification criteria on how 
to distinguish vertebral osteomyelitis from discitis 102, 106, 155. Regardless of the use of terminology 
antibiotic treatment is recommended by most authors 106, 110. 
 
Microbiology 
Microbiological findings were present in 27% of our arthritis patients and among patients classified 
to all diagnostic groups. In a Swedish population based study of adults, 45% had signs or a history 
of recent infection. We found elevated streptococcal antibodies to be the most frequent finding. The 
percentage of positive streptococcal tests was low in very young children and peaked at patients 
aged 8-11 years (35%).  Studies have found that the age-related incidence of ARF follows that of 
GAS pharyngitis and peaks between the ages of 6-15 years 156, 157. 
  Viral antibodies for recent infection were positive in < 5% of our patients. The role of 
viruses in arthritis patients needs further study. However, in line with Kunnamo et al, we believe 
that viral antibody screening is of limited use for the clinician 23.    
Positive bacterial cultures in the osteomyelitis patients were present in 43% of the patients; only 
26% of the acute osteomyelitis patients had a positive blood culture and no patient with subacute 
osteomyelitis had a positive blood culture. We and others found S. aureus to be the most common 
microbe 93, 94. A high proportion of positive blood cultures have been found in previous studies of 
acute osteomyelitis patients. Hence, the use of tissue cultures is probably more important now than 
was the case in earlier studies.   
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Predictors of JIA 
We found that transient arthritis was three times more frequent than JIA followed by post-
infectious arthritis which mainly comprised patients with PSRA.  
The following predictors were associated with JIA : female gender,  absence of mono 
arthritis and hip joint arthritis, the presence of knee joint arthritis, small joint arthritis, symptom 
duration of more than two weeks, normal neutrophile count, high platelet count, ANA, anti-CCP, 
IgM RF and HLA-B27.  
Predictors for JIA in undifferentiated arthritis patients have previously only been studied by 
Kunnamo et al 23. In patients with disease duration of more than two weeks, a low CRP value, the 
absence of fever and an elevated IgG were independent factors for chronic arthritis. A study from the 
UK showed that 94% of patients with more than two weeks disease duration had JIA 158. 
In line with other studies, immunological antibodies and HLA-B27 had a low sensitivity 
for JIA 3, 14, 116, 150, 159. As ANA screening only was positive in one of our arthritis patient without 
JIA the problem of false positive tests seems minor in children. That ANA positivity is one of the 
most important risk factors for iridocyclitis is accepted 159, 160. The HLA-B27 antigen is probably 
more common in the population in the northern parts of the Nordic countries than in the southern 
parts, ranging from 8 to 16% 161, 162. A recent Nordic study reported that HLA-B27 predicted a 
more extended disease in older boys with JIA 163.  
  We found a lower proportion of mono arthritis (64%) in JIA patients than in other types of 
arthritis. Polyarthritis have also found in 28% to 47% of children with post-infectious and para-
infectious arthritis, but they normally have a short disease duration 4, 23, 64, 164. Hence, we believe that 
involvement of more than four joints in patients with arthritis persisting for more than a few days may 
be associated with JIA.   
The finding of knee joint arthritis as an independent predictor for JIA must be interpreted 
carefully as we and others have found knee joint arthritis in several patients with post-infectious, 
infectious or transient arthritis (29-41%) 80, 165. 
However, small joint arthritis is probably an important factor as it was rarely found in patients 
without JIA in our study and has been found in several patients with JIA in other studies 5, 22, 165. 
A normal neutrofile count as a marker for the differentiation of JIA versus other groups of 
arthritis has as far as we know not been investigated earlier and warrants further study. The fact that 
JIA patients had a longer duration of symptoms before admission than patients with other types of 
arthritis could explain that this acute phase reactant was lower than in the other subgroups.  
A high platelet count predicted JIA in our study. Liang et al found higher levels of platelets in 
JIA than in reactive arthritis patients 165.An elevated level of platelets is a finding in many patients 
with chronic inflammation 166. 
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PSRA 
We found that patients with PSRA had a longer disease duration than patients with transient 
arthritis, this is in line with a previous study by Ahmed et al who found a mean duration of arthritis 
in PSRA patients of more than two months 46. We also found that the duration of symptoms before 
admission was shorter, hip arthritis was more frequent, and knee/ankle arthritis or other joint 
involvement, positive ANA and HLA-B27, and persistent arthritis were less frequent in the PSRA 
than in the JIA patients. A review also found that HLA-B27 is rare in PSRA patients 164. Although 
we used the proposed criteria for PSRA by Ayoub and Ahmed, it remains uncertain weather PSRA 
is a specific disease entity or if it is a heterogenous group of diseases in which some patients ought 
to be classified with JIA or transient arthritis 42, 164. 
 We believe that school-aged patients with recent onset arthritis should be tested for the 
presence of S. pyogenes as it is essential for the diagnosis of acute rheumatic fever and PSRA. In 
addition positive S. pyogenes tests assists in evaluating patients with disease duration of more than 
six weeks. Although our sample is small we do not have evidence that PSRA patients in Norway 
have a risk for carditis. A recently published retrospective Israeli study did not show carditis in any 
of the 159 PSRA patients examined 167. The subject of PSRA, carditis and duration of penicillin 
prophylaxis is controversial 47-49, 142, 164, 168, 169. Large population-based studies are needed to identify 
arthritis patients who need cardiological follow-up and treatment. Randomised-controlled trials 
should be assessed to find whether penicillin or penicillin prophylaxis can prevent carditis in 
children with PSRA. 
 
Characteristics of osteomyelitis 
We found that osteomyelitis patients and especially subacute osteomyelitis patients had few clinical 
and laboratory signs of inflammation. This is in contrast to several earlier studies on acute 
osteomyelitis, but could be linked to selection of patients 93, 102.  
ESR was the laboratory test with the highest positive predictive value in our study. The 
high sensitivity of ESR is in line with most previous studies99, 113, 170. However, CRP has been 
found to be more sensitive in microbiologically confirmed acute osteomyelitis and reflected 
recovery better than ESR and WBC 113.  
We also demonstrated that ESR was higher in osteomyelitis patients with a disease 
duration of <14 days than 14 days. This could indicate that a decrease in ESR in untreated patients 
can not exclude osteomyelitis in patients with persistent musculoskeletal signs and/or symptoms.  
On the other hand, patients who are admitted with a negative ESR and duration of symptoms of 
less than two weeks have a minimal risk of osteomyelitis. 
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MRI 
In our study MRI had a sensitivity of 100% and a positive predictive value of 85% for identifying 
osteomyelitis patients. In the literature the high sensitivity of MRI is based on adult patient series 
(mainly on diabetic foot) and a few paediatrics series. Some of the studies of non-diabetic patients 
are shown in table 8 125, 127, 129-132, 171, 172. We believe that based on MRI only, a poor defined bone 
marrow edema as a sign of osteomyelitis can be difficult or impossible to separate from bone 
edema in arthritis patients. Bone marrow edema has been found as a possible predictor of erosive 
progression in adult rheumatoid arthritis 173. 
 
Table 8. Sensitivity and specificity of MRI in the diagnosis of osteomyelitis* 
 
Author (ref) No. 
patients 
OM/not 
OM 
Technique Sensitivity Specificity Compared to Location Age, 
yr 
Evaluation 
Unger et al, 
1987 (125) 
12/23 T1W, T2W, PDV, 
GRE, STIR 
92 96 Histology or 
follow-up 
Mixed 1-80 Blinded, 2 
observers 
Erdman et al, 
1991 (127) 
54/56 T1W, T2W, PDV, 
STIR 
98 751, 822 Histology or 
culture 
Mixed 0-74 Limited 
clinical info, 
3 observers 
Zynamon et 
al,1991 (171)   
44/17 T1W, T2W, PDV, 
GRE 
100 78 Histology or  
culture or 
follow-up 
Mixed 1-83 Unknown 
Morrison et 
al,19931 
(132) 
34/15 T1W with and 
without Fat-sat, 
T2W, i.v. 
gadopentetate 
dimeglumine 
88 93 Histology or 
culture or 
follow-up 
Mixed 10-
80 
Blinded, 2 
observers 
Mazur et al, 
19951 (131) 
21/22 T1W, T2  97 92 Histology or 
follow-up 
Mixed 0-15 Open, 1 
observer 
Huang et al, 
1998 (172) 
44(57 
MRIs) 
T1W, T2W,  (STIR) 98 89 Histology or 
culture or 
follow-up 
Pelvis, 
hip 
22-
83 
Blinded 
Riise et al, 
20081 (III)         
35/92 T1W, STIR, (i.v  
contrast) 
100 93 Histology or 
culture or 
follow-up 
Mixed 0-15 Blinded, 2 
observers 
 
* Studies of diabetic foot, small studies or studies of poor quality are not presented; 1 prospective; 2 retrospective 
OM= osteomyelitis, T1W=T1-weigted, T2W=T2-weighted, PDW= proton-density weighted, GRE=gradient-recalled echo, 
STIR=short tau inversion recovery sequence, Fat-sat= fat saturation 
 
The MRI characteristics of acute osteomyelitis are ill defined bone marrow edema. In our 
study patients with disease duration of more than two weeks, 2/3 had sign of a subacute process. In 
a study by Erdman et al. 93% of the patients with more than four weeks disease duration had MRI 
signs of a subacute process 127. The sign of a subacute process is probably linked to time, bone 
involvement, age of the child, virulence of the bacteria, host factors and MRI techniques. 
We found that 31% of the osteomyelitis patients had increased signal and or thick synovia 
on MRI which could be interpreted as arthritis (paper III). This is in line with a study by Perlman et 
al 174. This could support that all patients with monoarthritis of more than two weeks duration 
should be tested by MRI. 
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By ordinary MRI, due to time and cost, only a limited part of the body can be examined. 
Whole-body MRI (WBMRI) is a new technique that could be of use in patients with possible 
osteomyelitis where the location is unknown or multiple 175. 
A systematic review of adult chronic osteomyelitis patients found that fluorodeoxyglucose 
positron emission tomography (PET) had a higher diagnostic accuracy for the diagnosis than MRI 
176
. The impact of PET scan in childhood osteomyelitis warrants further study.  
 
Early arthritis and osteomyelitis in a public health perspective 
Although patients with possible arthritis/and or osteomyelitis are frequently seen in paediatric 
wards primary care physicians have little experience with such cases. We therefore suggest that a 
child who appears well should be referred to a hospital within few days. Based on our findings and 
the literature we can predict the risk for severe and/or chronic disease in many patients 23, 69, 177.  
Based on reports from low-income countries we know that untreated cases of septic 
arthritis, osteomyelitis and ARF could cause considerable morbidity and some mortality 37, 178 179. 
Due to new and possible efficacious treatments for JIA it is believed that early intervention 
can limit joint destruction, growth-disturbances, osteoporosis and reduced quality of life 180-182. We 
are not aware of studies of health status and working ability in adults who had acute-, subacute- or 
chronic osteomyelitis in childhood. 
 Based on the epidemic in low-income countries, an economic analysis of ARF and rheumatic 
heart disease estimated that secondary prophylaxis was more effective than primary prophylaxis 
(US$142 per DALY [disability adjusted life years] gained and $5520 per death averted versus 
$1049 per DALY gained and $40920 per death averted) 183. Primary prophylaxis is also probably of 
limited value  because one study found that  less than 20% of patients with ARF  had throat 
symptoms that made them seek medical attention 184.  An effective vaccine against S. pyogenes 
could be available within some years. However, large subsidies are essential to give such a vaccine 
to the populations in need 185.  
In high income countries young children require general anaesthesia for tissue cultures and 
MRIs.  In-patient-care increases the costs, the risk of medical care complications and may also 
involve some children with spontaneous remission of signs and symptoms. 
From a public health perspective more research including cost-benefit analyses are needed 
to answer questions about identification of arthritis and osteomyelitis patients and the impact of 
early diagnosis and treatment. New diagnostic tools and treatment options continue to challenge a 
publicly financed health care system. 
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CONCLUSIONS 
- Arthritis is common in children, occurring in at least 0.7/1000 children per year. Twenty % of 
children presenting with early onset arthritis had JIA in the present study. The proportion and 
distribution of patients with septic, and post-infectious and transient arthritis was different from 
that reported in Finland 20 years ago. Geographical or genetical differences as well as 
environmental changes over time may influence the occurrence of childhood arthritis (paper I).  
 
- Septic arthritis and osteomyelitis were most common in patients under three years of age. The 
incidence rate in JIA tends to be bimodal with slightly higher incidence rates in the age group 1 to 
3 years and in school aged children. Hence patients < 3 years of age should be examined for septic 
arthritis, osteomyelitis and JIA (paper I, III). 
 
- Hip involvement is associated with transient arthritis, while hip arthritis rarely is the presenting 
symptom in JIA. Female gender, extended joint involvement, knee joint arthritis, small joint 
involvement, symptom duration > 2 weeks, high platelet count, neutrophile WBC-count in normal 
range, ANA, anti-CCP and HLA-B27 correlates with JIA (paper I, IV) 
 
- Signs of a recent or current infection were found in ¼ of the arthritis patients and in all subgroups. 
A viral antibody screen was of little clinical value (paper I). 
 
- The presence of S.pyogens is common in school aged children and can predict a prolonged disease 
course, but did not predict carditis in this small group of patients with arthritis associated to S. 
pyogenes (paper I, II). 
 
- The incidence of osteomyelitis in Norway remains high. Long bone involvement is probably less 
common than in earlier studies. Blood culture is insufficient to identify microbes in most cases 
(paper III). 
 
- Vertebral osteomyelitis was present in one of four osteomyelitis patients in our study (paper III). 
 
- MRI shows a high sensitivity and specificity for osteomyelitis. However, early signs are 
unspecific and must be compared with clinical history (paper III). 
 
- Patients with subacute osteomyelitis have more defined MRI characteristics, but the acute phase 
reactants may be normal (paper III).  
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ERRATA 
In paper IV the correct address of Øystein R. Riise is “Department of Paediatrics, Ullevål University 
Hospital and Department of Rheumatology, Rikshospitalet Medical Centre” 
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